Factor V Arg306 → Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese

Thrombosis and Haemostasis

Volumn 85, Issue 2, 2001, Pages 270-273

  Shen, M C ^a   Lin, J S ^a   Tsay, W ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Factor V; Factor V Arg306; Factor V Gly306; Taiwanese Chinese; Venous thrombophilia

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; GLYCINE;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; ECHOGRAPHY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TAIWAN; THROMBOPHILIA; VEIN THROMBOSIS; AMINO ACID SUBSTITUTION; FAMILY HEALTH; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; POINT MUTATION;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; DNA MUTATIONAL ANALYSIS; FACTOR V; FAMILY HEALTH; FEMALE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; PREVALENCE; TAIWAN; VENOUS THROMBOSIS;

EID: 0034746157     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615696     Document Type: Article

References (17)

1. Characterization of molecular defect in the FVR506Q
2. The mechanism of inactivation of human factor V and human factor Va by activated protein C
3. Anticoagulant protein C pathway defective in majority of thrombophilic patients
4. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects
5. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
6. Resistance to activated protein C as a basis for venous thrombosis
7. 506 → Gln mutation of factor V gene
8. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan
9. 306γThr) associated with resistance to activated protein C
10. 306 of factor V gene in Hong Kong Chinese
11. Familial thrombophilia due to a previous unrecognized mechanism characterize by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
12. The polymerase chain reaction with sequence specific primers for the detection of factor V mutation associated with activated protein C resistance
13. 306→Gly mutation in different human populations
14. 306 [arrow right] Gly mutation in venous thrombotic disease
15. Molecular mechanisms of activated protein C resistance
16. Activated protein C resistance: Molecular mechanisms
17. Cleavage of factor V at Arg506 by activated protein C and the expression of anticoagulant activity of factor V